ArticleMetabolism open2026
Baseline metabolite profiles predict the glucose-lowering efficacy of exenatide in patients with type 2 diabetes.
Yunyi Le et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it